3Swerdlow M. Mesothelioma of the pelvic peritoneum resembling papillary cystadenocarcinoma of the ovary[J]. Am J Obstet Gynecol, 1959,77(1) : 197 - 200.
4Lauchlan SC. The secondary Mullerian system revisited [ J ]. Int J Gynecol Pathol, 1994,13( 1 ) : 73 - 79.
5Chu CS, Menzin AW, Leonard DG, et al. Primary peritoneal carcinoma: a review of the literature [ J ]. Obstet Gynecol Surv, 1999, 54(5) :323 - 335.
6Shmueli E, Leider-Trejo L, Schwartz I, et al. Primary papillary serous carcinoma of the peritoneum in a man[J]. Ann Oncol, 2001, 12(4) : 563 - 567.
7Khalifeh I, Munkarah AR, Lonardo F, et ol. Expression of Cox-2, CD34, Bcl-2, and p53 and survival in patients with primary peritoneal serous carcinoma and primary ovarian serous carcinoma [J]. Int J Gynecol Pathol, 2004,23(2):162- 169.
8Mtaras MM, Bemheim J, Zehavi T, et al.Papillary serous carcinoma of the peritonecum coexisting with or after endometrial carcinoma [J]. Gynecol Oncol,2002,84(2):245 - 251.
9Ordonez NG. Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas[J]. Am J Surg Pathol, 1998,22(10) : 1203 - 1214.
10Bloss JD, Brady MF, Liao SY, et al. Extraovarian peritoneal remus papillary carcinoma: a phase Ⅱ trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma-a Gynecologic Oncology Gomp study[J].Gynecol Oncol, 2003, 89(1):148- 154.
